Business / Finance

RSS

Verde Media secures construction site in Asia with joint venture partner, Phoenix Energy

Verde Media Group Inc. through its Biotechnology Division (VMBD) is pleased to announce that it has secured its 40,000-square-foot construction site in Asia with joint venture partner, Phoenix Energy.

6 Jun 2014

Cegedim Relationship Management enters into strategic alliance with Scribe Software

Cegedim Relationship Management today announced that it has entered into a strategic partnership with Scribe Software, a recent winner of the prestigious Globee and Red Herring Top 100 awards, and now one of the fastest-growing cloud and software providers of data integration in the world.

6 Jun 2014

Spherix expands its operations in Texas

Spherix Incorporated, an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that it has expanded its operations in Texas through the opening of a new office located at 222 North Fredonia Street Longview, TX 75601.

5 Jun 2014

TowerJazz, Genoray collaborate to develop CIS detector for medical diagnostic devices

TowerJazz, the global specialty foundry leader, and Genoray Co. Ltd., a leading manufacturer of digital X-ray devices, today announced collaboration on the successful development of a CMOS image sensor (CIS) for medical diagnostic devices such as X-ray equipment, fluoroscopy and radiography.

5 Jun 2014

Thermo Fisher, Cellectis sign agreements on TALEN gene editing technology

Cellectis, a leader of engineered CART cell therapies, and Thermo Fisher Scientific announced today that they have entered into a series of agreements covering the uses of TAL nucleases under the brand name TALEN™.

5 Jun 2014

STENTYS signs agreement to acquire assets of Cappella Peel Away

STENTYS, a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), today announced the signing of the acquisition agreement of Cappella Peel Away Inc. (Delaware, USA) and its assets relating to a novel stent delivery system. The acquisition is subject to closing conditions.

5 Jun 2014

AMS agrees to sell Gamma Knife and radiation therapy services business in Turkey to Euromedic

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has entered into an agreement to sell its Gamma Knife and radiation therapy services business in Turkey to Euromedic Cancer Treatment Centers BV.

4 Jun 2014

Walgreens reports May sales of $6.57 billion

Walgreens had May sales of $6.57 billion, an increase of 6.0 percent from $6.19 billion for the same month in fiscal 2013.

4 Jun 2014

Envy Medical secures new growth capital from HCP & Company

Envy Medical, Inc., a leader in professional skincare products and services, announced today that it has secured new growth capital from HCP & Company, a middle-market private equity firm headquartered in Chicago.

4 Jun 2014

Leidos Holdings revenues decrease $1.32B to 17% in first quarter FY 2015

Leidos Holdings, Inc., a national security, health and engineering solutions company, today reported financial results for the first quarter of fiscal year 2015, which ended May 2, 2014.

4 Jun 2014

KineMed renews non-exclusive research collaboration with Pfizer

KineMed Inc. today announced the renewal of a non-exclusive research collaboration with Pfizer Inc. for the advancement of novel approaches in metabolic disease, in particular Type II diabetes.

4 Jun 2014

Glenmark Pharmaceuticals opens new monoclonal antibody manufacturing facility in Switzerland

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited, India (GPL), announced the opening of its new cGMP compliant monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland. T

4 Jun 2014

arGEN-X, Shire Pharmaceuticals announce long-term strategic alliance in therapeutic antibodies

arGEN-X, a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a long-term strategic alliance with Shire Pharmaceuticals.

4 Jun 2014

NeuroVive extends collaboration with Hospices Civils de Lyon

NeuroVive is extending its collaboration with Hospices Civils de Lyon (HCL) and Professor Ovize, which broadens the scope of NeuroVive's cardiovascular business area and creates the right conditions for the company to retain its leading position in mitochondrial medicine.

4 Jun 2014

Region Skåne and Sectra sign six-year agreement

Region Skåne, one of Sweden's largest care providers, has signed a six-year agreement with IT and medical technology company Sectra.

4 Jun 2014

Autifony Therapeutics awarded £2.2 million to progress first-in-class drug for tinnitus into Phase IIa study

Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for hearing disorders, today announced that it has been awarded funding of £2.2 million towards a Phase IIa clinical trial in tinnitus patients with its lead compound AUT00063, by the UK’s innovation agency, the Technology Strategy Board.

4 Jun 2014

Syngene International, Bristol-Myers Squibb extend drug discovery and development collaboration

Bristol-Myers Squibb and Syngene International, India's largest contract research organization, today announced a five-year extension of their drug discovery and development collaboration in India.

3 Jun 2014

UK makes £5.64M investment in most advanced crystallography technology

The UK's structural biology community will have access to the most advanced crystallography technology in the world thanks to a - £5.64M investment from UK research funders.

3 Jun 2014

Acadia Healthcare to acquire Partnerships in Care for $660M

Acadia Healthcare Company, Inc. today announced the signing of a definitive agreement to acquire Partnerships in Care (PiC) for approximately $660 million in cash.

3 Jun 2014

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Teva Pharmaceutical Industries Ltd., and Labrys Biologics, Inc., a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, today announced that Teva has entered into a definitive agreement to acquire Labrys, broadening Teva's array of biotechnology assets and capabilities.

3 Jun 2014

Business / Finance

Verde Media secures construction site in Asia with joint venture partner, Phoenix Energy

Cegedim Relationship Management enters into strategic alliance with Scribe Software

Spherix expands its operations in Texas

TowerJazz, Genoray collaborate to develop CIS detector for medical diagnostic devices

Thermo Fisher, Cellectis sign agreements on TALEN gene editing technology

STENTYS signs agreement to acquire assets of Cappella Peel Away

AMS agrees to sell Gamma Knife and radiation therapy services business in Turkey to Euromedic

Walgreens reports May sales of $6.57 billion

Envy Medical secures new growth capital from HCP & Company

Leidos Holdings revenues decrease $1.32B to 17% in first quarter FY 2015

KineMed renews non-exclusive research collaboration with Pfizer

Glenmark Pharmaceuticals opens new monoclonal antibody manufacturing facility in Switzerland

arGEN-X, Shire Pharmaceuticals announce long-term strategic alliance in therapeutic antibodies

NeuroVive extends collaboration with Hospices Civils de Lyon

Region Skåne and Sectra sign six-year agreement

Autifony Therapeutics awarded £2.2 million to progress first-in-class drug for tinnitus into Phase IIa study

Syngene International, Bristol-Myers Squibb extend drug discovery and development collaboration

UK makes £5.64M investment in most advanced crystallography technology

Acadia Healthcare to acquire Partnerships in Care for $660M

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News